Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference205 articles.
1. Bloch, R. G. et al. The clinical effects of isoniazid and iproniazid in the treatment of pulmonary tuberculosis. Ann. Intern. Med. 40, 881–900 (1954).
2. Keith, S. J. & Matthews, S. M. The value of psychiatric treatment: its efficacy in severe mental disorders. Psychopharmacol. Bull. 29, 427–430 (1993).
3. Moller, H. J. & Volz, H. P. Drug treatment of depression in the 1990s. An overview of achievements and future possibilities. Drugs 52, 625–638 (1996).
4. Blazer, D. G., Kessler, R. C., McGonagle, K. A. & Swartz, M. S. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am. J. Psychiatry 151, 979–986 (1994).
5. Greenberg, P. E. et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J. Clin. Psychiatry 64, 1465–1475 (2003). Estimates the economic burden of depression to have been relatively stable from 1990 to 2000. Of the total economic cost of depression in 2000 (US $83.1 billion), US $26.1 billion (31%) were direct medical costs, US $5.4 billion (7%) were suicide related mortality costs, and US $51.5 billion (62%) were workplace costs.
Cited by
187 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献